Filter
326
Text search:
pyrazinamide
Featured
60
98
Language
Document type
227
51
17
15
7
6
1
1
1
Countries
24
15
9
9
8
7
7
7
6
6
5
5
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
133
60
7
6
3
3
1
Toolboxes
175
26
8
6
4
4
4
4
3
3
1
1
Eur Respir J 2014; 43: 24–35 | DOI: 10.1183/09031936.00113413
Accessed December 2017
8–18 December 2015
Medicina (Kaunas) 2013;49(7):335-40
17–24 November 2015
4–15 February 2013
Eur Respir J. 2014 April ; 43(4): 1132–1141. doi:10.1183/09031936.00203613.
10–21 March 2014
Second Edition, 2012
Vol. 2: Clinicians' Guide
Clinicians’ Guide is designed to assist busy medical practitioners in the field with patient management by providing current, essential, practical guidance and background, packaged into a single resource
Clinicians’ Guide is designed to assist busy medical practitioners in the field with patient management by providing current, essential, practical guidance and background, packaged into a single resource
Public Health Action PHA 2017; 7(2): 110–115
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
